Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

Key Takeaways Arrowhead Pharmaceuticals reported a Phase-3 study of its medicine for a rare genetic disorder met all its ...

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

Shares of Arrowhead Pharmaceuticals on Tuesday climbed in pre-market trading after the company said that it plans to file a new drug application with the U.S. Food and Drug Administration by the end ...

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

Vanda pharmeucitals received a rejection for its drug tradipitant, causing the company management to criticize the FDA.

On World Alzheimer’s Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...

Turks and Caicos Islands, Turks and Caicos resident Vincent Wills, also known as “Big Leg,” 40, and Jamaican national Errol ...